Barclays PLC Kaleido Biosciences, Inc. Transaction History

Barclays PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.05 - $1.7 $157 - $5,348	-3,146 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.3 - $2.7 $26,477 - $54,990	-20,367 Reduced 86.62%	3,146 $5,000
Q4 2021 Feb 14, 2022	BUY	$2.39 - $6.02 $37,267 - $93,869	15,593 Added 196.88%	23,513 $56,000
Q3 2021 Nov 09, 2021	BUY	$5.36 - $7.99 $22,093 - $32,934	4,122 Added 108.53%	7,920 $43,000
Q2 2021 Aug 13, 2021	SELL	$5.82 - $8.72 $45,390 - $68,007	-7,799 Reduced 67.25%	3,798 $28,000
Q1 2021 May 13, 2021	BUY	$7.2 - $16.82 $55,497 - $129,648	7,708 Added 198.2%	11,597 $93,000
Q4 2020 Feb 11, 2021	SELL	$5.77 - $11.33 $8,153 - $16,009	-1,413 Reduced 26.65%	3,889 $35,000
Q3 2020 Nov 12, 2020	SELL	$5.09 - $11.07 $2,646 - $5,756	-520 Reduced 8.93%	5,302 $59,000
Q2 2020 Aug 12, 2020	BUY	$4.62 - $8.01 $9,457 - $16,396	2,047 Added 54.23%	5,822 $43,000
Q1 2020 May 13, 2020	SELL	$3.62 - $9.49 $27,468 - $72,010	-7,588 Reduced 66.78%	3,775 $23,000
Q4 2019 Feb 10, 2020	BUY	$5.02 - $8.87 $44,557 - $78,730	8,876 Added 356.9%	11,363 $57,000
Q3 2019 Nov 14, 2019	SELL	$6.74 - $11.3 $5,156 - $8,644	-765 Reduced 23.52%	2,487 $19,000
Q2 2019 Aug 14, 2019	SELL	$11.25 - $18.1 $6,693 - $10,769	-595 Reduced 15.47%	3,252 $38,000
Q1 2019 May 15, 2019	BUY	$12.71 - $15.0 $48,895 - $57,705	3,847 New	3,847 $56,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.